Home » Elizabeth Rose Lotsof

Elizabeth Rose Lotsof

Elizabeth Rose Lotsof

LinkedIn

Education: 

B.A. Chemistry: Biochemistry Concentration, Cum Laude

Minors in Educational studies and Anthropology, Washington University in St. Louis

From: Chicago, Illinois

Joined the David Lab: January 2017

Outside of lab: I enjoy kickboxing, skiing, music concerts, dancing and baking.

Research in David Lab:

The NEIL family of DNA glycosylases are critical enzymes to maintaining the integrity of the genome. They initiate the base excision repair (BER) pathway by cleaving the N-glycosidic bond between the oxidatively damaged base and the sugar. NEIL1 and NEIL3 have a unique ability to excise a wide variety of substrates and remove lesions from alternative DNA contexts. Because of these abilities, I am currently evaluating the ability of NEIL1 and NEIL3 to excise oxidative base damage from G-quadruplex structures. G-quadruplexes DNA structures that occur in sequences that contain three or four adjacent guanines, which can Hoogsteen hydrogen-bond together to from a G-quartet. These G-quartets will stack together with a central K+ or Na+ ion to stabilize the structure in a variety of conformations. What makes the G-quadruples so notable is their location in the promoter sequences of many oncogenes and BER glycosylases, NEIL1 and NEIL3, and they have been implicated in down- or up-regulating gene transcription. Additionally, due to their high G content, G-quadruplexes are prime spots for oxidative damage necessitating repair by the BER pathway. NEIL’s ability to cleave from such structures suggest a dynamic relationship between DNA repair and gene regulation.

Previous Research Experience:

I previously worked as a Research Coordinator for the NorthShore University Health System’s Division of Urogynecology, where I studied the factors that impact patient persistence with urological medication and the relationship between different Urogynecological surgeries and their post-operative results, in addition to managing ongoing clinical trials.  In addition to my research work, I am passionate about science communication and accessibility and helping those with rare genetic diseases. I hope to one day have a career with a biotechnology company focused on therapeutics for individuals with rare genetic diseases.

RSS Science Daily News

  • 'Dancing molecules' heal cartilage damage July 26, 2024
    New therapy uses synthetic nanofibers to mimic the natural signaling of a protein that is crucial for cartilage formation and maintenance. Researchers found that intensifying the motion of molecules within the nanofibers led to more components needed for regeneration. After just four hours, the treatment activated the gene expression necessary to generate cartilage. Therapy could […]
  • New understanding of fly behavior has potential application in robotics, public safety July 26, 2024
    Scientists have identified an automatic behavior in flies that helps them assess wind conditions -- its presence and direction -- before deploying a strategy to follow a scent to its source. The fact that they can do this is surprising -- can you tell if there's a gentle breeze if you stick your head out […]
  • Lampreys possess a 'jaw-dropping' evolutionary origin July 26, 2024
    Lampreys are one of only two living jawless vertebrates Jaws are formed by a key stem cell population called the neural crest New research reveals the gene regulatory changes that may explain morphological differences between jawed and jawless vertebrates.
  • Researchers develop state-of-the-art device to make artificial intelligence more energy efficient July 26, 2024
    Engineering researchers have demonstrated a state-of-the-art hardware device that could reduce energy consumption for artificial intelligent (AI) computing applications by a factor of at least 1,000.
  • New drug shows promise in clearing HIV from brain July 25, 2024
    An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new study. By targeting infected cells in the brain, drug may clear virus from hidden areas that have been a major challenge in HIV treatment.

Contact:

Dr. Sheila S. David
ssdavid@ucdavis.edu
(530)-752-4280

Department of Chemistry
One Shields Ave.
Davis, CA 95616